Are you Dr. Andrey?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 87 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
10666 N Torrey Pines Rd
La Jolla, CA 92037Phone+1 858-554-8632
Summary
- Dr. Jeffrey Andrey, MD is an oncologist in La Jolla, California. He is currently licensed to practice medicine in California, Georgia, and Illinois. He is affiliated with Scripps Green Hospital, Scripps Memorial Hospital-La Jolla, and Naval Medical Center San Diego.
Education & Training
Loyola University Medical CenterFellowship, Hematology and Medical Oncology, 1994 - 1997- Loyola University Medical CenterResidency, Internal Medicine, 1991 - 1994
Loyola University Chicago Stritch School of MedicineClass of 1991
Certifications & Licensure
CA State Medical License 1997 - 2025
IL State Medical License 1991 - 2002
GA State Medical License 1997 - 1997- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Super Doctor SuperDoctors.com
- Top MD Consumers Checkbook
Clinical Trials
- Comparison of Fluconazole vs Voriconazole to Treat Fungal Infections for Blood and Marrow Transplants (BMT CTN 0101) Start of enrollment: 2003 Nov 01
- Nonmyeloablative Allogeneic Transplant Start of enrollment: 2001 Oct 01
- A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) Start of enrollment: 2011 Oct 01
- Join now to see all
Publications & Presentations
PubMed
- 49 citationsTransplantation for autoimmune diseases in north and South America: a report of the Center for International Blood and Marrow Transplant Research.Marcelo C. Pasquini, Júlio César Voltarelli, Harold L. Atkins, Nelson Hamerschlak, Xiaobo Zhong
Biology of Blood and Marrow Transplantation. 2012-10-01 - 90 citationsPhase I Trial of Toll-Like Receptor 9 Agonist PF-3512676 with and Following Rituximab in Patients with Recurrent Indolent and Aggressive Non–Hodgkin's LymphomaJohn P. Leonard, Brian K. Link, Christos Emmanouilides, Stephanie A. Gregory, Daniel J. Weisdorf
Clinical Cancer Research. 2007-10-15 - 10 citationsTherapeutic advances in the treatment of hairy cell leukemia.Jeffrey Andrey, Alan Saven
Leukemia Research. 2001-05-01
Press Mentions
Jeffrey Andrey, M.D. Joins the Oncology Institute of Hope and InnovationJune 5th, 2019
Professional Memberships
- Member
